Compare Iris Energy Limited (IREN) vs 22nd Century Group Inc (XXII) Price & Performance

IREN stock surged 19.57% to $40.20, driven by $2.8 billion in new AI cloud contracts and a raised 2026 revenue target above $4 billion. Despite recent earnings misses, the company shows strong revenue growth momentum with 2025 revenue at $501 million and projected 2026 revenue of $757 million. Technical indicators remain bearish overall, though oscillators are neutral, with key resistance at $42 and support at $37.

The outlook is mixed: strong AI contract wins and analyst bullishness (71% buy ratings, $79.11 consensus target) support upside potential, but execution risks, negative ROE/ROA, and high valuation multiples (P/E 52.21, P/S 15.61) pose significant challenges. Investors should weigh growth prospects against fundamental weaknesses and volatility in the competitive AI infrastructure space.

XXII trades at $4.32, down 0.23% on the day, with neutral technical signals and bearish moving averages. The company shows significant financial challenges with negative profit margins (-65.76% net income margin) and declining revenue, though analyst sentiment remains positive with 75% buy ratings. Recent corporate actions include a 20:1 reverse stock split completed in June 2026, while expansion initiatives in California and New York aim to drive VLN brand growth.

The outlook remains speculative with high execution risk given persistent losses and negative ROE (-130.19%). Investment opportunity hinges on successful commercialization of reduced-nicotine products and FDA regulatory progress, but substantial financial deterioration and competitive pressures present significant downside risk for shareholders.